- ISIN
- US81728J1097
- CUSIP
- 81728J109
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Jun 3, 2016
Highlights
- Market Cap
- $47.90M
- Enterprise Value
- $30.25M
- EPS (TTM)
- -$0.47
- Total Revenue (TTM)
- $22.53M
- Gross Profit (TTM)
- $8.51M
- EBITDA (TTM)
- -$8.57M
- Year Range
- $2.66 - $5.67
- Target Price
- $6.00
- ROA (TTM)
- -15.08%
- ROE (TTM)
- -17.07%
- Avg. Volume (1M)
- 21K
- Avg. Volume Value (1M)
- $62.62K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SRTS Performance Chart
Sensus Healthcare, Inc. (SRTS) is down 26.9% since the beginning of the year. At $3 per share, SRTS is trading 48.6% below its 52-week high of $6. Investors who bought $1,000 worth of SRTS shares 5 years ago would now be looking at an investment worth $784.
Loading charts...
Compare this symbol against anything
Returns By Period
Sensus Healthcare, Inc. (SRTS) has returned -26.88% so far this year and -47.85% over the past 12 months. Over the last ten years, SRTS has returned -7.22% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Sensus Healthcare, Inc.
- 1D
- 0.69%
- 1M
- -5.21%
- 6M
- -43.27%
- YTD
- -26.88%
- 1Y
- -47.85%
- 3Y*
- 0.35%
- 5Y*
- -4.74%
- 10Y*
- -7.22%
- ALL TIME*
- -7.19%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
SRTS Monthly Returns History
Based on dividend-adjusted daily data since Jul 26, 2016, SRTS's average daily return is +0.08%, while the average monthly return is +1.14%. At this rate, an investment would double in approximately 5.1 years.
Historically, 45% of months were positive and 55% were negative. The best month was Nov 2021 with a return of +53.5%, while the worst month was Nov 2022 at -52.5%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.
On a daily basis, SRTS closed higher 47% of trading days. The best single day was May 10, 2024 with a return of +38.9%, while the worst single day was Nov 4, 2022 at -51.2%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 28.89% | -19.88% | -3.16% | -0.25% | -22.17% | -2.27% | -3.64% | -26.88% | |||||
| 2025 | 19.00% | -41.96% | -1.05% | -9.09% | 10.70% | -0.42% | 17.93% | -39.36% | -7.37% | 1.59% | 31.35% | -5.01% | -42.49% |
| 2024 | 37.71% | 26.15% | -7.32% | -1.05% | 44.15% | -1.66% | 19.51% | 2.35% | -11.04% | 10.34% | 32.97% | -18.68% | 193.22% |
| 2023 | 23.18% | -24.84% | -24.16% | -9.21% | -43.13% | 17.10% | -4.76% | 3.67% | -10.93% | -20.94% | 10.50% | -2.48% | -68.19% |
| 2022 | 6.79% | 36.58% | -3.89% | -30.24% | 22.80% | -11.42% | 46.61% | 10.57% | 0.64% | 12.29% | -52.52% | 11.08% | 2.77% |
| 2021 | -3.11% | 22.19% | -16.19% | 0.52% | -6.49% | 6.94% | -3.64% | -4.04% | 1.12% | 11.11% | 53.50% | 17.59% | 87.05% |
Benchmark Metrics
Sensus Healthcare, Inc. has an annualized alpha of 10.20%, beta of 0.78, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since July 26, 2016.
- This stock participated in 100.47% of S&P 500 Index downside but only 24.34% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 10.20%
- Beta
- 0.78
- R²
- 0.04
- Upside Capture
- 24.34%
- Downside Capture
- 100.47%
Return for Risk
Risk / Return Rank
SRTS ranks 13 for risk / return — above 13% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Sensus Healthcare, Inc. (SRTS) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SRTS | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.07 | ||
| Sortino ratioReturn per unit of downside risk | -2.62 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.25 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | -0.93 | 2.00 | -2.93 |
| Martin ratioReturn relative to average drawdown | -1.37 | 8.49 | -9.86 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Sensus Healthcare, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Sensus Healthcare, Inc. was 87.51%, occurring on Nov 13, 2023. The portfolio has not yet recovered.
The current Sensus Healthcare, Inc. drawdown is 80.56%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-87.51%Nov 2023 | 1y 3mo | — | 3y 11moAug 2022 - now | — |
-80.17%May 2020 | 1y 1mo | 1y 9mo | 2y 11moMar 2019 - Feb 2022 | — |
-46.56%Jul 2017 | 11mo 9d | 9mo 16d | 1y 8moAug 2016 - May 2018 | — |
-40.37%Apr 2022 | 1mo 5d | 3mo 8d | 4mo 13dMar 2022 - Aug 2022 | Bear market2022 |
-39.11%Nov 2018 | 1mo 28d | 3mo 16d | 5mo 14dOct 2018 - Mar 2019 | Rate-hike selloffLate 2018 |
Drawdown Indicators
| SRTS | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.51% | -56.78% | -30.73% |
Max Drawdown (1Y)Largest decline over 1 year | -51.79% | -9.10% | -42.69% |
Max Drawdown (3Y)Largest decline over 3 years | -70.08% | -18.90% | -51.18% |
Max Drawdown (5Y)Largest decline over 5 years | -87.51% | -25.43% | -62.08% |
Max Drawdown (10Y)Largest decline over 10 years | -87.51% | -33.92% | -53.59% |
Current DrawdownCurrent decline from peak | -80.56% | -1.58% | -78.98% |
Average DrawdownAverage peak-to-trough decline | -47.12% | -10.70% | -36.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.25% | 2.14% | +33.11% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Sensus Healthcare, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Sensus Healthcare, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SRTS relative to other companies in the Medical Devices industry. Currently, SRTS has a P/S ratio of 2.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SRTS in comparison with other companies in the Medical Devices industry. Currently, SRTS has a P/B value of 1.1. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SRTS
Add Sensus Healthcare, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SRTS